Diagnosed Multiple Myeloma (MM) on a Phase 2 Trial Receiving Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd)

被引：0

作者：

Derman, Ben A. ^{[1
]}

Kubicki, Tadeusz ^{[2
]}

Simmons, Heidi ^{[3
]}

Afrough, Aimaz ^{[4
]}

Zonder, Jeffrey A. ^{[5
]}

Grinblatt, David L. ^{[6
]}

Anderson, Larry D., Jr. ^{[7
]}

Kin, Andrew ^{[8
]}

Narula, Sunil

Rayani, Shayan ^{[1
]}

Gurbuxani, Sandeep ^{[9
]}

Karrison, Theodore ^{[2
]}

Jiang, Ken ^{[2
]}

Major, Ajay ^{[10
]}

Cooperrider, Jennifer H. ^{[2
]}

Jacob, Allison P. ^{[11
]}

Jakubowiak, Andrzej J. ^{[1
]}

机构：

[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA

[2] Univ Chicago, Chicago, IL 60637 USA

[3] Adapt Biotechnol Corp, Seattle, WA USA

[4] UT Southwestern Med Ctr, Dallas, TX USA

[5] Karmanos Canc Inst, Detroit, MI USA

[6] NorthShore Univ HealthSyst, Evanston, IL USA

[7] UT Southwestern Med Ctr, Hematol Malignancies & Cellular Therapy, Dallas, TX USA

[8] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[9] Univ Chicago, Dept Pathol, Chicago, IL USA

[10] Univ Colorado, Ctr Canc, Aurora, CO USA

[11] Med Affairs, Adapt Biotechnol, Seattle, WA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-182410

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM).
Derman, Benjamin Avi
Zonder, Jeffrey A.
Kansagra, Ankit J.
Grinblatt, David L.
Narula, Sunil
Rayani, Shayan
Stefka, Andrew T.
Jiang, Ken
Major, Sarah
Wolfe, Brittany
Whelan, Megan
Libao, Bernadette
McIver, Amanda
Andreatos, Evangelia
Juergens, Daniel
Alcantar, Luis
Karrison, Theodore
Bishop, Michael Russell
Jasielec, Jagoda
Jakubowiak, Andrzej J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[2] A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
Bhutani, Manisha
Foureau, David M.
Robinson, Myra
Guo, Fei
Fesenkova, Kateryna
Atrash, Shebli
Paul, Barry
Varga, Cindy
Friend, Reed
Pineda-Roman, Mauricio
Rigby, Katherine
Symanowski, James T.
Norek, Sarah
Tucker, Mallory R.
Druhan, Lawrence J.
Voorhees, Peter M.
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 535 - +
[3] Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)
Foureau, David M.
Bhutani, Manisha
Guo, Fei
Fesenkova, Kateryna
Atrash, Shebli
Friend, Reed
Paul, Barry
Robinson, Myra M.
Symanowski, James T.
Druhan, Lawrence J.
Pineda-Roman, Mauricio
Voorhees, Peter M.
Usmani, Saad Z.
BLOOD, 2021, 138
[4] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
Tan, Carlyn Rose
Derkach, Andriy
Nemirovsky, David
Ciardiello, Amanda
Diamond, Benjamin
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi
Maclachlan, Kylee
Patel, Dhwani
Lahoud, Oscar B. B.
Landau, Heather J. J.
Chung, David J. J.
Shah, Gunjan L. L.
Scordo, Michael
Giralt, Sergio A. A.
Lesokhin, Alexander
Usmani, Saad Z. Z.
Landgren, Ola
Korde, Neha
BLOOD CANCER JOURNAL, 2023, 13 (01)
[5] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
Carlyn Rose Tan
Andriy Derkach
David Nemirovsky
Amanda Ciardiello
Benjamin Diamond
Malin Hultcrantz
Hani Hassoun
Sham Mailankody
Urvi Shah
Kylee Maclachlan
Dhwani Patel
Oscar B. Lahoud
Heather J. Landau
David J. Chung
Gunjan L. Shah
Michael Scordo
Sergio A. Giralt
Alexander Lesokhin
Saad Z. Usmani
Ola Landgren
Neha Korde
Blood Cancer Journal, 13
[6] Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Therapy in High-Risk Newly Diagnosed Multiple Myeloma
Tan, Carlyn
Korde, Neha
Derkach, Andriy
Hultcrantz, Malin
Maclachlan, Kylee H.
Hassoun, Hani
Mailankody, Sham
Shah, Urvi A.
Rajeeve, Sridevi
Patel, Dhwani
Lesokhin, Alexander
Lahoud, Oscar Boutros
Shah, Gunjan L.
Scordo, Michael
Chung, David
Landau, Heather
Giralt, Sergio A.
Hofmeister, Craig C.
Kaufman, Jonathan L.
Nooka, Ajay K.
Usmani, Saad Z.
Lonial, Sagar
Joseph, Nisha S.
BLOOD, 2023, 142
[7] Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Piedra, Katrina
Peterson, Tim
Tan, Carlyn
Orozco, Jennifer
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Lesokhin, Alexander
Shah, Urvi
Lu, Sydney
Patel, Dhwani
Derkach, Andriy
Wilkins, Cy R.
Korde, Neha
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 105 - 109
[8] CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE (KRD) WITH OR WITHOUT TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA PATIENTS: SUBGROUP ANALYSIS IN THE FORTE TRIAL
Gay, F.
Cerrato, C.
Petrucci, M. T.
Zambello, R.
Rivolti, E.
Ballanti, S.
Omede, P.
Gentile, M.
Bernardini, A.
Narni, F.
Capra, A.
De Sabbata, G.
Gozzetti, A.
Galieni, P.
Rizzi, R.
Pescosta, N.
Cea, M.
Molica, S.
Cafro, A.
Musolino, C.
Spadano, A.
Montefusco, V.
Musto, P.
Cavo, M.
Boccadoro, M.
HAEMATOLOGICA, 2019, 104 : 2 - 3
[9] Carfilzomib, Lenalidomide and Dexamethasone (KRd) Vs Bortezomib, Lenalidomide, and Dexamethasone (VRd) As Induction Therapy in Newly Diagnosed High-Risk Multiple Myeloma
Tan, Carlyn
Nemirovsky, David
Derkach, Andriy
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi A.
Patel, Dhwani
Maclachlan, Kylee H.
Lahoud, Oscar B.
Shah, Gunjan L.
Scordo, Michael
Chung, David J.
Landau, Heather
Giralt, Sergio A.
Lesokhin, Alexander M.
Korde, Neha
Usmani, Saad
BLOOD, 2022, 140 : 1817 - 1819
[10] A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
Derman, Ben A.
Major, Ajay
Rosenblatt, Jacalyn
Avigan, David
Rampurwala, Murtuza M.
Alcantar, Luis
Libao, Bernadette M.
McIver, Amanda
Andreatos, Evangelia
Major, Sarah
Wolfe, Brittany
Gorski, Martha
Karrison, Theodore G.
Stefka, Andrew
Jakubowiak, Andrzej
BLOOD, 2021, 138

← 1 2 3 4 5 →